Hongchang International Co., Ltd

HCIL ·Healthcare, Medical Devices
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $188.2K $3.2M $6.6M $1.7M $1.1M $1.7M
Cost of Revenue $70.0K $2.8M $4.9M $727.9K $222.8K $170.6K $352.5K
Gross Profit $118.3K $385.6K $1.7M $936.2K $859.6K $1.5M $8.2M
Gross Margin 62.8% 12.1% 26.2% 56.3% 79.4% 90.0%
Operating Expenses
Research & Development $54.2K $214.9K $225.0K $236.3K $231.3K $235.3K $386.2K
SG&A Expense $54.1K $319.0K $1.6M $1.8M $1.2M $1.6M $2.9M $6.3M
Operating Income $-54.1K $-287.9K $-1.6M $-509.4K $-737.0K $-1.1M $-1.7M $504.6K
Operating Margin -153.0% -50.2% -7.7% -44.3% -106.2% -99.1%
Interest Expense $1.0K $1.2K
Pretax Income $-54.1K $-498.8K $-1.2M $-1.4M $-1.7M $455.2K
Income Tax Expense $-92.7K $536 $-691.9K $395.0K
Net Income $-54.1K $-158.5K $-3.5M $-498.8K $-3.7M $-811.5K $-1.0M $46.8K
Net Margin -84.2% -111.5% -7.6% -221.3% -75.0% -58.8%
EPS (Basic) $0.00 $0.00 $-0.01 $0.00 $-0.01 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $-0.01 $0.00 $-0.01 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 720.1M 696.0M 696.0M 696.0M 696.0M 696.0M 696.0M 655.5M
Shares Outstanding (Diluted) 720.1M 696.0M 696.0M 696.0M 696.0M 696.0M 696.0M 655.5M
Dividends Per Share
← Newer Page 2 of 2 Older →